Creative Planning Athenex, Inc. Transaction History

Creative Planning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$7.11 - $13.76 $924,399 - $1.79 Million	-130,014 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$5.71 - $15.85 $37,971 - $105,402	-6,650 Reduced 4.87%	130,014 $1.01 Million
Q4 2019 Jan 30, 2020	SELL	$9.6 - $17.75 $100,800 - $186,375	-10,500 Reduced 7.13%	136,664 $2.09 Million
Q2 2019 Jul 26, 2019	SELL	$9.44 - $19.8 $10,714 - $22,473	-1,135 Reduced 0.77%	147,164 $2.91 Million
Q4 2018 Feb 01, 2019	SELL	$10.24 - $15.49 $335,267 - $507,158	-32,741 Reduced 18.08%	148,299 $1.88 Million
Q1 2018 Apr 18, 2018	BUY	$13.53 - $17.47 $2.12 Million - $2.74 Million	156,855 Added 648.56%	181,040 $3.08 Million
Q4 2017 Jan 17, 2018	SELL	$14.41 - $19.15 $2.35 Million - $3.12 Million	-162,755 Reduced 87.06%	24,185 $385,000
Q3 2017 Oct 17, 2017	BUY	$13.5 - $19.51 $2.52 Million - $3.65 Million	186,940	186,940 $3.27 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.